ÂÜÀòÂÒÂ×

Ed Rosen is an accomplished executive with extensive experience in the life sciences and medical device sectors, currently serving as an Independent Director at Prolocor since March 2023. Previously, Rosen was the Chief Strategy and Commercial Officer at Clinical Genomics, where commercialization strategies for a colorectal cancer recurrence test were defined and implemented. As the Founder and Managing Partner of Glendevon Life Sciences LLC, Rosen focused on accelerating the commercialization of novel intellectual property. Rosen’s past roles include President and CEO of Elucida Oncology, where innovative cancer detection and treatment technologies were developed, as well as positions at Johnson & Johnson in various global marketing leadership roles. Ed Rosen holds a BA (Honors) in Business from the University of Lincoln.